Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Fresenius Kabi Oncology

BSE: 532545|NSE: FKONCO|ISIN: INE575G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Fresenius Kabi Oncology is not traded in the last 30 days
Fresenius Kabi Oncology is not traded in the last 30 days
Announcements on Fresenius Kabi

14th-Oct-2013 12:05Source: BSE

Fresenius Kabi- Updates on Delisting Offer

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this public corrigendum (“Corrigendum”) to the Public Delisti...

14th-Oct-2013 11:33Source: NSE

Fresenius Kabi Oncology Limited

DSP Merrill Lynch Limited has informed the Exchange regarding Corrigendum ("Corrigendum") to the Public Announcement issued pertaining to the delisting offer made by Fresenius Kabi (Singapore) Pte Ltd...

14th-Oct-2013 11:06Source: NSE

Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited has informed the Exchange that the promoter of the Company i.e. Fresenius Kabi (Singapore) Pte Ltd. ("FKSL ) has informed that in terms of paragraph 20.1 of the public ...

12th-Oct-2013 12:35Source: BSE

Fresenius Kabi- Delisting update

Fresenius Kabi Oncology Ltd has informed BSE that the promoter of the Company i.e. Fresenius Kabi (Singapore) Pte Ltd. (“FKSL”) has informed that in terms of paragraph 20.1 of the public announcem...

8th-Oct-2013 08:40Source: NSE

Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited has informed the Exchange that Mr. Rajiv Lochan Jain has been appointed as an Additional Director of the Company w.e.f. October 03, 2013 under "Independent Category" vi...

8th-Oct-2013 08:19Source: BSE

Fresenius Kabi- Appointment of Director

Fresenius Kabi Oncology Ltd has informed BSE that Mr. Rajiv Lochan Jain has been appointed as an Additional Director of the Company w.e.f. October 03, 2013 under "Independent Category" via Board of Di...

17th-Sep-2013 13:20Source: BSE

Fresenius Kabi- Delisting Offer

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behlaf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this public announcement (“Public Announcement”) to the publi...

17th-Sep-2013 12:01Source: NSE

Fresenius Kabi Oncology Limited

DSP Merrill Lynch Limited has submitted to the Exchange a copy of public announcement ("Public Announcement") issued by Fresenius Kabi (Singapore) Pte Ltd. ("Acquirer") to the public shareholders of F...

17th-Sep-2013 08:47Source: BSE

Fresenius Kabi- Delisting Update

Fresenius Kabi Oncology Ltd has informed BSE that the promoter of the Company i.e. Fresenius Kabi (Singapore) Pte Ltd. has made a public announcement to the public shareholders of Fresenius Kabi Oncol...

11th-Sep-2013 09:28Source: BSE

Fresenius Kabi- SAT Order

With reference to earlier announcement dated August 03, 2013, Fresenius Kabi Oncology Ltd has now informed BSE that Hon''ble Securities Appellate Tribunal, Mumbai (SAT), vide its order dated September...

Quick Links for Fresenius Kabi Oncology
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.